Search Results

Mammoth Biosciences is a biotechnology company focused on leveraging its proprietary ultracompact CRISPR systems to develop long-term curative therapies, as well as other applications such as decentralized precision diagnostics.

Business

Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) and Mammoth Biosciences, Inc., today announced a collaboration to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types.

April 25, 2024

·

10 min read

Press Releases

Mammoth Biosciences Announces New Results on NanoCas – the First Efficient Ultracompact Extrahepatic Gene Editor

January 31, 2025

·

4 min read

Press Releases

Mammoth Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference

January 8, 2025

·

1 min read

Business

Jennifer Doudna’s Mammoth Links with Vertex in $700 Million Ultra-Small CRISPR Deal

Mammoth Biosciences just announced a collaboration with Vertex to develop in vivo gene-editing therapeutics for patients with either of two serious, but not-yet-disclosed diseases.

October 26, 2021

·

4 min read

·

Gail Dutton

Biotech Bay

Mammoth Biosciences Raises $45 Million to Build Next Generation CRISPR Products For Therapeutics and Diagnostics

Already the leader in CRISPR-based disease detection, the latest round will drive Mammoth’s robust platform for protein discovery to extend into gene-editing and therapeutics applications.

February 5, 2020

·

4 min read

Biotech Bay

Mammoth Biosciences to Present at Annual Meeting of the American Society of Gene & Cell Therapy

Mammoth Biosciences today announced that Lucas Harrington, Ph.D., Mammoth’s co-founder and Chief Scientific Officer, will present new preclinical data at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting in Baltimore, May 7 - 11, 2024.

May 2, 2024

·

3 min read

Biotech Bay

Mammoth Biosciences to Present at the 2023 Annual Meeting of the American Society of Gene and Cell Therapy

Mammoth Biosciences today announced Janice Chen, Ph.D., chief technology officer and co-founder of Mammoth, will present at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting in Los Angeles, CA, May 16 - 20, 2023.

May 8, 2023

·

2 min read

Biotech Bay

Mammoth Biosciences to Present at 41st Annual J.P. Morgan Healthcare Conference

Mammoth Biosciences, Inc. today announced its participation in the upcoming 41st Annual J.P. Morgan Healthcare Conference in San Francisco, CA.

January 5, 2023

·

1 min read

Business

Mammoth Biosciences Announces Appointment of Phil Tinmouth, Siang Chin to Key Leadership Roles

Mammoth Biosciences, Inc., a biotechnology company building the next generation of CRISPR products with a mission to cure and detect diseases, announced the appointment of Phil Tinmouth as Chief Business Officer and Siang Chin as General Counsel.

December 5, 2022

·

3 min read